Min et al. found that antigen-capturing nanoparticles (AC-NPs) enhanced the presentation of tumor-derived protein antigens (TDPA) by APCs, resulting in stronger activation of CD8+ T cells (Min et al., 2017). Here, CD8A is linked to neoplasm.